Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FRANK BERENSON

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1689740987
CMS profile
31637
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$64,784.18

299 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 299 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FRANK BERENSON

NPI 1689740987 · CMS profile ID 31637

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 299 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1689740987?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FRANK BERENSON, NPI 1689740987, CMS profile ID 31637. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 299 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1689740987?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). FRANK BERENSON, NPI 1689740987, CMS profile ID 31637. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 299 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1689740987?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
FRANK BERENSON, NPI 1689740987, CMS profile ID 31637, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 299 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1689740987?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

299 matching records · $64,784.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 299 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 299.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Greenwich Biosciences, Inc. $12.7410/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841833357 CMS
Lundbeck LLC $23.7010/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845898589 CMS
Eisai Inc. $15.4110/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818019869 CMS
Teva Pharmaceuticals USA, Inc. $16.9110/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839557651 CMS
AbbVie Inc. $8.1710/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042809 CMS
Adlon Therapeutics L.P. $23.5610/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844822193 CMS
Sunovion Pharmaceuticals Inc. $24.6710/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821544293 CMS
AbbVie Inc. $8.8610/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042805 CMS
Ipsen Biopharmaceuticals, Inc $14.6710/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841909621 CMS
AbbVie Inc. $8.7410/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042801 CMS
AbbVie Inc. $1,750.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042797 CMS
AbbVie Inc. $6.3010/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042793 CMS
AbbVie Inc. $8.8509/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042789 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.4209/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819864403 CMS
Tris Pharma Inc $18.6109/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851955043 CMS
Eisai Inc. $24.4509/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818019941 CMS
AbbVie Inc. $9.3409/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042785 CMS
AbbVie Inc. $8.7609/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042781 CMS
Biohaven Pharmaceuticals, Inc. $9.6109/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852426187 CMS
UCB, Inc. $32.6009/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807401147 CMS
AbbVie Inc. $4.8609/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042773 CMS
AbbVie Inc. $8.1509/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042777 CMS
Eisai Inc. $17.2709/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818019833 CMS
AbbVie Inc. $8.7409/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042769 CMS
SK Life Science, Inc. $22.5109/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826828065 CMS
Biohaven Pharmaceuticals, Inc. $24.5509/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852426183 CMS
Teva Pharmaceuticals USA, Inc. $103.3109/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839557435 CMS
Teva Pharmaceuticals USA, Inc. $2,860.0009/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839557735 CMS
AbbVie Inc. $17.8409/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042765 CMS
Greenwich Biosciences, Inc. $14.0509/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841833343 CMS
Greenwich Biosciences, Inc. $0.6509/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841833351 CMS
Supernus Pharmaceuticals, Inc. $5.0009/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845006149 CMS
UPSHER-SMITH LABORATORIES LLC $21.2109/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834697079 CMS
Allergan, Inc. $28.5109/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792706323 CMS
AbbVie Inc. $9.6809/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042761 CMS
Teva Pharmaceuticals USA, Inc. $14.8009/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839557647 CMS
UPSHER-SMITH LABORATORIES LLC $15.1909/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834697041 CMS
Neurelis, Inc. $21.6309/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842859837 CMS
AbbVie Inc. $8.1508/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042757 CMS
AQUESTIVE THERAPEUTICS, INC. $17.5408/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 847838089 CMS
AbbVie Inc. $8.8608/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042753 CMS
Eisai Inc. $21.0508/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817989029 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8.7408/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819864401 CMS
UCB, Inc. $28.9708/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807406691 CMS
Supernus Pharmaceuticals, Inc. $23.4208/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845006145 CMS
AbbVie Inc. $8.7208/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794042749 CMS
Greenwich Biosciences, Inc. $19.9808/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841833329 CMS
UPSHER-SMITH LABORATORIES LLC $18.9508/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834696919 CMS
Ipsen Biopharmaceuticals, Inc $19.5508/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841906897 CMS
Zogenix Inc. $12.8808/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854235241 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $68,041.84 233
PY2020 $70,553.32 289
PY2021 $64,784.18 299
PY2022 $130,281.39 388
PY2023 $48,780.46 258
PY2024 $58,092.67 264
PY2025 $86,907.35 313

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $22,771.35 12
PY2024 Principal investigator $25,032.24 12
PY2023 Principal investigator $72,861.56 17
PY2022 Principal investigator $44,659.01 10
PY2021 Recipient $1,200.00 1
PY2021 Principal investigator $101,855.04 38
PY2020 Recipient $4,147.50 2
PY2020 Principal investigator $189,467.56 39
PY2019 Recipient $1,617.78 2
PY2019 Principal investigator $221,581.64 46

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,440.00 12/31/2025 Non-covered Recipient Entity
PANDA NEUROLOGY AND SOUTHEAST CENTER FOR HEADACHES
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-attack Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202533081
Principal investigator 1 ABBVIE INC. $2,390.85 12/04/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202526934
Principal investigator 1 ABBVIE INC. $2,106.00 10/09/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202513759
Principal investigator 1 ABBVIE INC. $395.55 07/02/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202495899
Principal investigator 1 ABBVIE INC. $395.55 06/03/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202487429
Principal investigator 1 ABBVIE INC. $2,308.50 06/03/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH CENTER OF ATLANTA
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202487433
Principal investigator 1 ABBVIE INC. $1,846.80 05/06/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH CENTER OF ATLANTA
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202481239
Principal investigator 1 ABBVIE INC. $2,216.70 05/06/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202481241
Principal investigator 1 ABBVIE INC. $1,518.75 03/06/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202458542
Principal investigator 1 ABBVIE INC. $3,870.45 03/06/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH CENTER OF ATLANTA
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202458670
Principal investigator 1 ABBVIE INC. $1,846.80 02/05/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH CENTER OF ATLANTA
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202445246
Principal investigator 1 ABBVIE INC. $2,435.40 02/05/2025 Non-covered Recipient Entity
CLINICAL INTEGRATIVE RESEARCH
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202445250